Page 39 - Hawkary2017

Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC is a fast growing multinational
pharmaceutical group which was founded in 1978 in Jordan. Hikma
develops, manufactures and markets a broad range of both branded
and non-branded generic and in-licensed products. Hikma is
committed to the highest quality manufacturing with multiple FDA
approved facilities. Hikma operates in the US, Europe and across the
MENA region. Growth in MENA is driven by strong demographics
and growing investment in healthcare. Hikma is the fourth listed
pharmaceutical company in the FTSE 250.

Operations are in 27 manufacturing facilities in 11 countries - FDA
approved facilities in 5 countries with cost effective R&D and
manufacturing.

Our strategy for growth is to strengthen our leading position in
the MENA region, develop our global product range in
growing therapeutic areas, extend our reach and diversity
as partner of choice in the MENA region, increase the
scale of our specialty injectables business, leverage our
expertise and capacity in the US market, build on our
world-class manufacturing and API sourcing
capabilities.